MitoQ
Mitochondria-targeted antioxidant that may improve vascular function and reduce oxidative stress markers in specific populations.
Our methodology: How we evaluate supplements and turn the underlying research into a single rating.
This supplement may interact with medications, medical conditions or sensitive populations. Review safety before use.
Expensive niche antioxidant with preliminary vascular benefits; skip unless cost is no concern.
MitoQ is a mitochondria-targeted coenzyme Q10 analog synthesized by linking ubiquinone to a lipophilic triphenylphosphonium cation; it is not found in food. The molecule concentrates inside mitochondria, where it neutralizes reactive oxygen species at their source and preserves membrane potential. Human trials suggest modest improvements in endothelial function in older adults and reduced oxidative stress biomarkers in chronic disease, though data are limited and mixed.
Potential benefits
Protocol
Onset Time
Who Should Consider
How It Works
The triphenylphosphonium cation drives MitoQ into mitochondria against the electrochemical gradient, achieving concentrations hundreds of times higher than standard CoQ10. Within the matrix, the ubiquinone head is recycled by the respiratory chain to neutralize superoxide and lipid peroxides locally, limiting oxidative damage to mitochondrial DNA and membranes without systemic distribution.
Put MitoQ in context.
Compare the closest evidence-ranked options, or see how this supplement fits your goals and what you already take.
Is MitoQ right for your goals?
Answer four quick questions for recommendations that already account for the supplement you just reviewed.
Keep comparing
Related options by shared goals, evidence, and verified pairings.